Details for New Drug Application (NDA): 206046
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 206046
| Tradename: | OLOPATADINE HYDROCHLORIDE |
| Applicant: | Bausch And Lomb Inc |
| Ingredient: | olopatadine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 206046
| Mechanism of Action | Histamine H1 Receptor Antagonists |
| Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 206046
Suppliers and Packaging for NDA: 206046
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206046 | ANDA | WALGREEN COMPANY | 0363-0867 | 0363-0867-01 | 1 BOTTLE in 1 CARTON (0363-0867-01) / 5 mL in 1 BOTTLE |
| OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206046 | ANDA | RUGBY LABORATORIES | 0536-1445 | 0536-1445-40 | 1 BOTTLE in 1 CARTON (0536-1445-40) / 5 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Jul 26, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
